Abstract:Abstract To pursue a systematic approach for discovery of potential mechanisms of action and new therapeutic use of traditional herbal medicines, we used DNA microarray, bioinformatics and the “Connectivity Map” (CMAP) analysis to investigate the gene expression profiling of Chinese herbal medicines. We demonstrated that this approach can be used to elucidate novel molecular mechanisms for the Chinese medicinal formula Si-Wu-Tang (SWT) which is widely used for women's health in Asian countries. The human breast cancer MCF-7 cells treated with beta-estradiol (E2, 0.1 µM) or SWT extract (0.0256, 0.256, and 2.56 mg/ml) for six hours showed significant gene expression changes. The differentially expressed genes related to SWT treatment were used to compare with the gene expression profiles of 1,309 compounds in the CMAP database. Such comparison revealed that the CMAP profile of E2-treated MCF-7 cells showed an excellent match with SWT treatment (permutation p<0.00001), consistent with SWT's widely claimed use for women's diseases and suggesting a phytoestrogen effect. Many genes strongly up-regulated by E2 were similarly upregulated by SWT, e.g., GREB1, a well-known estrogen regulated gene. Of interest with regard to the potential cancer preventive activity of SWT, the oncogenes MYBL1 and cyclin D1 were found to be strongly induced by E2 but not by SWT. In addition, SWT inhibited expression of estrogen receptor (ER)-alpha, but not ER-beta. Consistently, at low concentration (1.5 and 3.0 mg/ml), SWT stimulated MCF-7 (ER-positive) cell growth, while at high concentration (> 6.0 mg/ml), it inhibited the growth of MCF-7. The combination of SWT with tamoxifen, a selective estrogen receptor modulator, demonstrated enhanced growth inhibitory effects on MCF-7 cells. The results our study suggest that SWT may possess a non-toxic chemopreventive effect for human breast cancer. This study also demonstrated the feasibility of using microarray gene expression profiling in combination with the CMAP data mining to discover new molecular signature that are present in natural products. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 2575. doi:1538-7445.AM2012-2575

Utilization of Gene Expression Signature for Quality Control of Traditional Chinese Medicine Formula Si-Wu-Tang

Global Detection And Identification Of Components From Crude And Processed Traditional Chinese Medicine By Liquid Chromatography Connected With Hybrid Ion Trap And Time-Of-Flight-Mass Spectrometry

Deciphering the Differentiations of Traditional Chinese Medicine Analogous Formulae by Parallel Liquid Chromatography-Mass Spectrometry Coupled with Microplate-Based Assays

Discovery Of Molecular Mechanisms Of Traditional Chinese Medicinal Formula Si-Wu-Tang Using Gene Expression Microarray And Connectivity Map

Evaluating The Pharmacological Mechanism Of Chinese Medicine Si-Wu-Tang Through Multi-Level Data Integration

Dna Microarray And Connectivity Map Analysis Reveals Estrogen-Like Activity Of Chinese Medicinal Formula Si-Wu-Tang

Liquid chromatography-mass spectrometry-based strategy for systematic profiling of chemical components and associated quantitative analysis of quality markers in Qi-Wei-Tong-Bi oral liquid

Transcriptional profiling of Chinese medicinal formula Si-Wu-Tang on breast cancer cells reveals phytoestrogenic activity

A bio-activity guided in vitro pharmacokinetic method to improve the quality control of Chinese medicines, application to Si Wu Tang

A multistep approach for exploring quality markers of Shengjiang Xiexin decoction by integrating plasma pharmacochemistry-pharmacokinetics-pharmacology

Novel chinmedomics strategy for discovering effective constituents from ShenQiWan acting on ShenYangXu syndrome

Chromatographic Fingerprint Analysis Is Feasible For Comprehensive Quality Control Of Taohongsiwu

A novel and comprehensive strategy for quality control in complex Chinese medicine formula using UHPLC-Q-Orbitrap HRMS and UHPLC-MS/MS combined with network pharmacology analysis: Take Tangshen formula as an example

A strategy for intelligent chemical profiling-guided precise quantitation of multi-components in traditional Chinese medicine formulae-QiangHuoShengShi decoction

An Integrated Strategy for Global Qualitative and Quantitative Profiling of Traditional Chinese Medicine Formulas: Baoyuan Decoction as a Case

High-Throughput In Vitro Gene Expression Profile to Screen of Natural Herbals for Breast Cancer Treatment

Simultaneous Quantification of 50 Bioactive Compounds of the Traditional Chinese Medicine Formula Gegen-Qinlian Decoction Using Ultra-High Performance Liquid Chromatography Coupled with Tandem Mass Spectrometry

Biological Ingredient Analysis of Traditional Chinese Medicine Preparation Based on High-Throughput Sequencing: the Story for Liuwei Dihuang Wan.

An integrated chinmedomics strategy for discovery of effective constituents from traditional herbal medicine

The Potential of Metabolic Fingerprinting As a Tool for the Modernisation of TCM Preparations.

Metabolite profiling of traditional Chinese medicine formula Dan Zhi Tablet: An integrated strategy based on UPLC-QTOF/MS combined with multivariate statistical analysis.